VOGLIBITE-GM2/0.3
Rs 146.4 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
VOGLIBITE-GM2/0.3
Voglibite GM 2 0.3 mg Tablets offer a combined approach to managing symptoms of vestibular disorders and Meniere's disease. Each tablet contains 0.3 mg of Betahistine dihydrochloride, which helps to improve blood flow within the inner ear, thereby alleviating symptoms such as dizziness, vertigo, and tinnitus. Additionally, the tablets include 80 mg of Ginkgo Biloba extract, known for its cognitive and circulatory benefits. This combination ensures comprehensive symptom relief by addressing both inner ear function and overall circulation. The tablets are formulated for convenience, providing an easy-to-swallow option for precise dosing. Packaged in a bottle of 10 tablets, Voglibite GM 2 is effective for both short-term relief and ongoing symptom management, helping to improve quality of life by targeting the underlying causes of vestibular symptoms and supporting overall health.
Product Highlights and Usage:
Active Ingredients: Each tablet contains 0.3 mg of Betahistine dihydrochloride and 80 mg of Ginkgo Biloba extract, combining two effective components. Dual Therapeutic Action: Combines Betahistine to enhance inner ear circulation and manage symptoms like dizziness and vertigo, with Ginkgo Biloba to support cognitive function and improve peripheral circulation. Effective Symptom Relief: Provides relief from symptoms associated with vestibular disorders and Meniere's disease, including dizziness, vertigo, and tinnitus. Convenient Tablet Form: Easy-to-swallow tablets for accurate dosing and convenience in daily use. 10-Tablet Pack: Available in a pack of 10 tablets, suitable for short-term or long-term management.
How it works:
VOGLIBITE GM 2/0.3MG TABLET helps manage type 2 diabetes mellitus through a combination of actions. Glimepiride lowers blood glucose levels by enhancing insulin release from the pancreas. Metformin reduces glucose production in the liver and decreases glucose absorption in the stomach and intestines, also improving the body’s insulin response. Voglibose works by inhibiting the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars. This action slows the digestion and absorption of carbohydrates in the small intestine, resulting in lower blood glucose levels in individuals with type 2 diabetes mellitus.
Directions for use:
Take VOGLIBITE GM 2/0.3MG TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY VOGLIBITE GM 2/0.3MG TABLET is not recommended during pregnancy as it may harm the fetus. Consult your doctor before use. BREASTFEEDING VOGLIBITE GM 2/0.3MG TABLET is not recommended for breastfeeding women as it may pass into breast milk and potentially harm the nursing child. Consult your doctor before use. DRIVING AND USING MACHINES Use VOGLIBITE GM 2/0.3MG TABLET with caution if you experience impaired alertness or reactions due to hypoglycemia. Avoid driving or operating machinery if these symptoms occur. ALCOHOL Consult your doctor before drinking alcohol while taking VOGLIBITE GM 2/0.3MG TABLET, as it may lower your blood sugar levels. KIDNEY VOGLIBITE GM 2/0.3MG TABLET is not recommended for patients with severe kidney failure and should be used with caution in those with other kidney conditions. Consult your doctor before use. LIVER VOGLIBITE GM 2/0.3MG TABLET is not recommended for patients with severe liver disease and should be used with caution in those with other liver conditions. Consult your doctor before use. ALLERGY Do not use VOGLIBITE GM 2/0.3MG TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas, sulphonamides, or any other ingredients in this medicine. LUNGS VOGLIBITE GM 2/0.3MG TABLET is not recommended for patients with lung issues such as acute or chronic respiratory failure. Consult your doctor before use. HEART DISEASE VOGLIBITE GM 2/0.3MG TABLET is not recommended for patients with heart problems, including recent heart attacks, chronic heart failure, or cardiogenic shock. Consult your doctor before use. USE IN PEDIATRICS VOGLIBITE GM 2/0.3MG TABLET is not recommended for children and adolescents under 18 years due to insufficient data on its safety and effectiveness. Consult your doctor before use. USE IN GERIATRICS Use VOGLIBITE GM 2/0.3MG TABLET with caution in elderly patients aged 65 years and above. Consult your doctor before use.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$